Efficacy and safety of PCSK9 inhibitors in patients with chronic kidney disease
Authors
- Bi‐Cheng Liu (ORCID: https://orcid.org/0000-0002-4584-1853)
- Xiaoliang Zhang (ORCID: https://orcid.org/0000-0002-2224-6373)
- Hong Liu
- Xiaomin Li (ORCID: https://orcid.org/0000-0002-0051-3354)
- Haixia Tang (ORCID: https://orcid.org/0009-0007-1072-7018)
- Fengmei Wang (ORCID: https://orcid.org/0000-0002-9438-9859)
- Bin Wang (ORCID: https://orcid.org/0000-0002-7166-0482)
Institutions
- Zhongda Hospital Southeast University (CN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2025-08-19
- DOI
- https://doi.org/10.1186/s12882-025-04347-1
- Citations
- 2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Jiangsu Commission of Health
- Nanjing Medical University
- Changjiang Scholar Program of Chinese Ministry of Education